Polar Capital appoints Caroline Gulliver as Director

Published 06/05/2025, 09:24
Polar Capital appoints Caroline Gulliver as Director

LONDON - Polar Capital Global Healthcare Trust plc has announced the appointment of Ms. Caroline Gulliver as an independent non-executive Director, effective from May 15, 2025. Ms. Gulliver’s appointment comes as part of the company’s board enhancement strategy, leveraging her significant experience in investment trusts.

Caroline Gulliver has a notable background, including her current roles as a non-executive director, Senior Independent (LON:IOG) Director (SID), and audit committee chair at MIGO Opportunities Trust Plc and abrdn European Logistics Income PLC. Her previous tenure included being a non-executive director and audit committee chair of International Biotechnology Trust plc. Gulliver’s extensive experience also encompasses her time as an Executive Director at Ernst & Young, where she developed a deep understanding of investment trusts.

Lisa Arnold, Chair of Polar Capital Global Healthcare Trust, expressed enthusiasm for Gulliver’s agreement to join the Board. Arnold anticipates that Gulliver’s extensive experience and skill set will greatly benefit the company. Gulliver is set to become the Audit Chair-Elect and will transition into the role through an orderly handover from Neal Ransome, the current Audit Chair, who will complete his nine-year tenure in 2026.

The election of Ms. Gulliver as a non-executive director will be proposed to the shareholders at the company’s next Annual General Meeting, scheduled for early 2026. It has been noted that Ms. Gulliver does not currently hold any shares in Polar Capital Global Healthcare Trust plc. According to the company’s statement, there are no additional details that need to be disclosed under the Listing Rules concerning Ms. Gulliver’s appointment.

This strategic addition to the Board is part of Polar Capital’s ongoing efforts to strengthen its governance and oversight capabilities. The information regarding Ms. Gulliver’s appointment is based on a press release statement.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.